tiprankstipranks
Purple Biotech (PPBT)
NASDAQ:PPBT
US Market
Holding PPBT?
Track your performance easily

Purple Biotech (PPBT) Ownership - Who Owns Purple Biotech?

974 Followers

Purple Biotech (PPBT) Ownership Overview

6.11%93.89%
6.11% Other Institutional Investors
93.89% Public Companies and Individual Investors
The ownership structure of Purple Biotech (PPBT) stock is a mix of institutional, retail, and individual investors. , and 93.89% is owned by Public Companies and Individual Investors.
The ownership structure of Purple Biotech (PPBT) stock is a mix of institutional, retail, and individual investors. , 6.11% is owned by Insiders

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Purple Biotech (PPBT)?
Currently, no data Available
What percentage of Purple Biotech (PPBT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.11% of Purple Biotech (PPBT) stock is held by institutional investors.
    What percentage of Purple Biotech (PPBT) stock is held by retail investors?
    According to the latest TipRanks data, approximately 93.89% of Purple Biotech (PPBT) stock is held by retail investors.
      Who owns the most shares of Purple Biotech (PPBT)?
      Currently, no data Available
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis